Correlation Engine 2.0
Clear Search sequence regions

  • adult (7)
  • arthritis (1)
  • chemotaxis (1)
  • cytokines (4)
  • disease adult (2)
  • disease and (2)
  • fever (1)
  • humans (1)
  • IL 1β (1)
  • IL 6 (7)
  • leukocytosis (1)
  • macrophages (2)
  • neutrophils (1)
  • pathogenesis (1)
  • skin rash (1)
  • still (9)
  • t cells (1)
  • Sizes of these terms reflect their relevance to your search.

    Adult-onset Still's disease is a systemic inflammatory disease characterized by high spiking fever, arthritis, evanescent skin rash, leukocytosis, and hyperferritinemia. The pathogenesis of adult-onset Still's disease has not been fully understood yet; however, multiple proinflammatory cytokines, such as IL-1β and IL-6, play important roles in the development of adult-onset Still's disease. IL-6 is a multifunctional cytokine that accelerates the differentiation of macrophages and cytotoxic T-cells and chemotaxis of neutrophils and macrophages. Serum concentrations of IL-6 well correlate with disease activity of adult-onset Still's disease, and blockade of IL-6 has been proven to be effective in active adult-onset Still's disease. This review will focus on the recent understanding of the role of proinflammatory cytokines of adult-onset Still's disease and the efficacy of IL-6 inhibitors for the treatment of adult-onset Still's disease. © Japan College of Rheumatology 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail:


    Yuko Kaneko. Interluekin-6 inhibitors for the treatment of adult-onset Still's disease. Modern rheumatology. 2022 Jan 05;32(1):12-15

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 34894252

    View Full Text